{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.36","value":"0.3"},{"groupId":"OG001","spread":"0.70","value":"0.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"197"},{"groupId":"OG001","value":"196"}],"units":"Participants"}],"description":"The duration of use of IV antibiotics was defined as the number of days in which IV antibiotics were administered","dispersionType":"Standard Deviation","groups":[{"description":"F-627, 20 mg fixed dose pre-filled syringe, administered on Day 2 of each of 4 chemotherapy cycles.\n\nF-627: single dose pre-filled syringe","id":"OG000","title":"F-627"},{"description":"6 mg fixed dose Neulasta®, administered on Day 2 of each of 4 chemotherapy cycles\n\nNeulasta: single dose pre-filled syringe","id":"OG001","title":"Neulasta"}],"paramType":"MEAN","populationDescription":"ITT (Intent-to-Treat) population","reportingStatus":"POSTED","timeFrame":"across all 4 chemotherapy cycles (average 84 days)","title":"Duration in Days of Use of Intravenous Antibiotic","type":"SECONDARY","unitOfMeasure":"days"}